Charles River Laboratories | CRL - Interest Expense On Debt



Charles River Laboratories reported $29.97M in Interest Expense on Debt for its fiscal quarter ending in June of 2025.


Interest Expense On Debt Change Date
Agilent USD 28M 1000K Jul/2025
Align Technology 0 0 Sep/2024
Bio-Rad Laboratories USD 12.4M 400K Jun/2025
Bruker USD 15.7M 2.6M Jun/2025
Cardinal Health USD 74M 0 Jun/2025
Charles River Laboratories USD 29.97M 2.08M Jun/2025
Cigna USD 337M 25M Jun/2025
CVS Health USD 763M 22M Jun/2025
Danaher USD 71M 1000K Jun/2025
Dentsply International USD 24M 1000K Jun/2025
Elevance Health USD 341M 3M Jun/2025
Galapagos EUR 780K 49.34M Mar/2025
Hologic USD 28.9M 200K Jun/2025
Humana USD 157M 3M Jun/2025
Illumina USD 25M 0 Jun/2025
Incyte USD 594K 66K Jun/2025
IQVIA Holdings USD 182M 17M Jun/2025
Laboratory Of America USD 57.1M 1.1M Jun/2025
Lonza CHF 70M 11M Dec/2024
McKesson USD 49M 4M Jun/2025
Merck 79M 1000K Jun/2025
Mettler Toledo International USD 16.78M 126K Jun/2025
Novartis USD 289M 19M Jun/2025
Pfizer USD 654M 0 Jun/2025
Quest Diagnostics USD 67M 5M Jun/2025
Revvity USD 22.94M 27K Jun/2025
Thermo Fisher Scientific USD 404M 101M Jun/2025
United Therapeutics USD 7.3M 1.2M Jun/2025
UnitedHealth USD 1.03B 29M Jun/2025
Waters USD 14.35M 84K Jun/2025
West Pharmaceutical Services USD 100K 300K Jun/2025